PHAXIAM Therapeutics SA (PHXM) Stock Price, Quote, News and Overview

What is the stock price of PHAXIAM Therapeutics SA today?

The current stock price of PHXM is 3.1 USD. The price decreased by -0.64% in the last trading session.

What is the ticker symbol for PHAXIAM Therapeutics SA stock?

The exchange symbol of PHAXIAM Therapeutics SA is PHXM and it is listed on the Nasdaq exchange.

On which exchange is PHXM stock listed?

PHXM stock is listed on the Nasdaq exchange.

What is the price forecast or stock price prediction for PHAXIAM Therapeutics SA stock?

8 analysts have analysed PHXM and the average price target is 10.17 USD. This implies a price increase of 228.04% is expected in the next year compared to the current price of 3.1. Check the PHAXIAM Therapeutics SA stock analysts ratings, price target forecast and up-and down grades for more detailed information.

What is PHAXIAM Therapeutics SA worth?

PHAXIAM Therapeutics SA (PHXM) has a market capitalization of 18.83M USD. This makes PHXM a Nano Cap stock.

How many employees does PHAXIAM Therapeutics SA have?

PHAXIAM Therapeutics SA (PHXM) currently has 49 employees.

What are the support and resistance levels for PHAXIAM Therapeutics SA (PHXM) stock?

PHAXIAM Therapeutics SA (PHXM) has a resistance level at 3.11. Check the full technical report for a detailed analysis of PHXM support and resistance levels.

Is PHAXIAM Therapeutics SA (PHXM) expected to grow?

The Revenue of PHAXIAM Therapeutics SA (PHXM) is expected to decline by -100% in the next year. Check the estimates tab for more information on the PHXM EPS, Sales, EBIT and EBITDA future analyst estimates.

Should I buy PHAXIAM Therapeutics SA (PHXM) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:

• The Technical Analysis (TA) tab contains a technical analysis of PHXM, looking at technical quality and support and resistance levels
• The Fundamental Analysis (FA) tab contains a fundamental analysis of PHXM, evaluating the profitability, health, valuation and growth aspects
• PHAXIAM Therapeutics SA (PHXM) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
• PHAXIAM Therapeutics SA (PHXM) Sales and EPS estimates to see what analysts future expectations are.
• PHAXIAM Therapeutics SA (PHXM) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
• PHAXIAM Therapeutics SA (PHXM) Insider and Institutional Ownership to learn about the owners and their transactions.
• PHAXIAM Therapeutics SA (PHXM) Stock Chart to make your own analysis
• PHAXIAM Therapeutics SA (PHXM) Latest news and press-releases to stay up to date.

Does PHAXIAM Therapeutics SA (PHXM) stock pay dividends?

PHXM does not pay a dividend.

When does PHAXIAM Therapeutics SA (PHXM) report earnings?

PHAXIAM Therapeutics SA (PHXM) will report earnings on 2024-03-20, after the market close.

What is the Price/Earnings (PE) ratio of PHAXIAM Therapeutics SA (PHXM)?

PHAXIAM Therapeutics SA (PHXM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.04).

ChartMill assigns a fundamental rating of 2 / 10 to PHXM. Both the profitability and financial health of PHXM have multiple concerns.

Over the last trailing twelve months PHXM reported a non-GAAP Earnings per Share(EPS) of -0.04. The EPS increased by 99.68% compared to the year before.

ChartMill assigns a Buy % Consensus number of 85% to PHXM. The Buy consensus is the average rating of analysts ratings from 8 analysts.

For the next year, analysts expect an EPS growth of 77.73% and a revenue growth -100% for PHXM